July 12, 2011 โ€“ To streamline diagnosis and enable greater overall exam efficiency, Toshiba America Medical Systems Inc. has announced U.S. Food and Drug Administration (FDA) approval of VirtualExplorer Version 3.1, a software upgrade package for Toshiba Magnetic Resonance (MR) VirtualExplorer workstations. The software provides enhanced post-processing functionality, and the new cardiac package includes MR flow analysis, which allows clinicians to measure flow and velocity when imaging the heart.

July 12, 2011โ€“ A heart valve developer that was spun-off out of Cleveland Clinic to develop a lifetime heart valve replacement technology platform featuring exchangeable bioprosthetic leaflets has received $3.5 million in equity investment from CryoLife Inc.

July 12, 2011 โ€“ The Society of Cardiovascular Computed Tomography (SCCT) has published the SCCT Guidelines on Radiation Dose and Dose-Optimization Strategies in Cardiovascular CT document, which will be printed in the July/August special Radiation Focus issue of the Journal of Cardiovascular Computed Tomography. This guideline document reviews available data and provides recommendations regarding interpretation of radiation dose indices and predictors of risk, appropriate use of scanner acquisition modes and settings, development of algorithms for dose optimization and establishment of procedures for dose monitoring.

July 12, 2011 โ€“ The Interlock-35 Fibered IDC Occlusion System has been launched in the United States and Europe. Earlier this year, the system, manufactured by Boston Scientific, received clearance from the U.S. Food and Drug Administration (FDA) and CE mark approval for obstructing or reducing blood flow in the peripheral vasculature during embolization procedures.

July 7, 2011 โ€“ The National Aeronautics and Space Administration (NASA)โ€™s Ames Research Center and The Midura Laboratory selected ImageIQ to assist in their study of space flight-induced vascular alterations in the lower leg. ImageIQ will provide customized image acquisition and analysis for a vascular research study aboard NASA's final mission of the shuttle Atlantis. scheduled for July 8. The company provides imaging analytics software engineering and visualization services for research, medical device and pharmaceutical organizations.

July 5, 2011 โ€” Janssen Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban tablets), a novel, once-daily, oral anticoagulant for the prevention (prophylaxis) of deep vein thrombosis (DVT) which may lead to a pulmonary embolism (PE) in people undergoing knee or hip replacement surgery.

July 5, 2011 โ€” ECRI Institute, an independent nonprofit that researches the best approaches to improving patient care, and the Health Care Improvement Foundation, an independent nonprofit corporation with a multi-dimensional focus on healthcare safety, announced the launch of a new Partnership for Patient Care regional collaborative focused on improving computed tomography (CT) radiation safety. Jointly funded by Philadelphia-area hospitals and Independence Blue Cross, this collaborative will engage hospitals and imaging centers in Philadelphia and surrounding counties in a 12-month project aimed at strengthening patient safety specific to CT imaging.

Subscribe to
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now